You have 9 free searches left this month | for more free features.

pf-06823859

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)

Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus, Cutaneous
  • Placebo
  • PF-06823859
  • (no location specified)
May 18, 2023

Myositis Trial in Upland, Orlando, Saint Louis (PF-06823859, Placebo)

Recruiting
  • Myositis
  • PF-06823859
  • Placebo
  • Upland, California
  • +4 more
May 29, 2023

Healthy Trial in Shinjuku-ku (PF-06823859, Placebo)

Completed
  • Healthy
  • PF-06823859
  • Placebo
  • Shinjuku-ku, Tokyo, Japan
    Medical Corporation Shinanokai Shinanozaka Clinic
May 23, 2022

Healthy Trial in New Haven (PF-06823859, Placebo injection SC/IV)

Completed
  • Healthy
  • PF-06823859
  • Placebo injection SC/IV
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Nov 13, 2017